Tiffany Beauvais
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Tiffany Beauvais has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Nathalie Labarrière
Nantes Université, Univ Angers, CHU Nantes, INSERM, CNRS, Immunology and New Concepts in ImmunoTherapy, INCIT, UMR 1302/EMR6001
2 shared publications - Amir Khammari
Department of Dermatology, CHU Nantes, CIC 1413, INSERM UMR 1302/EMR6001 INCIT, Nantes University, Nantes, France
1 shared publication - Amélie Guiho
INCIT, INSERM 1302, Labex IGO, Universitéd’Angers, Nantes Université
1 shared publication - Audrey Guilbaud
Nantes Universite, Universite d'Angers, Inserm, Immunology and New Concepts in ImmunoTherapy, INCIT, UMR 1302, Nantes, France
1 shared publication - Baptiste Lottin
Nantes Universite, Universite d'Angers, Inserm, Immunology and New Concepts in ImmunoTherapy, INCIT, UMR 1302, Nantes, France
1 shared publication - Barbara Mouratou
CRCNA, INSERM, CNRS, Université d'Angers, Université de Nantes, Nantes, France
1 shared publication
Latest Publications
- Open Access
- 2 August 2025
- Published by Taylor & Francis in OncoImmunology
- Vol. 14 (1) , 2538684
Systematic identification of lincRNA-derived immunogenic peptides in melanoma
The search for reliable shared tumor-specific antigens (TSAs) to improve cancer immunotherapy is on-going. The so-called non-coding regions of the genome have recently been shown to give rise to immunogenic peptides, including the melanoma-specific antigen MELOE-1 which is translated from the long intergenic non-coding RNA (lincRNA) meloe in an IRES-dependent manner. Here, we present a strategy to systematically identify tumor-specific antigens produced by ORFs within lincRNAs with IRES-like upstream structures. We provide evidence suggesting that in the melanocytic lineage a significant proportion of the selected lincRNAs can produce immunogenic peptides. T cell repertoires against some of these peptides were found in peripheral blood mononuclear cells (PBMCs) from healthy donors and melanoma patients, and in tumor-infiltrating lymphocytes (TILs) from metastatic melanoma patients. Finally, CD8+ T cell lines from melanoma patients specific for three of the characterized HLA-A *0201 epitopes could recognize melanoma cell lines, which were enhanced by reticular stress. Thus, these peptides may represent a new class of shared TSAs in melanoma and are attractive candidates for evaluation as targets for immunotherapy in preclinical studies. In addition, our selection strategy has the potential to identify new lincRNA-derived antigens in other cancers.
- 2 August 2025
- Published by Taylor & Francis in OncoImmunology
- Vol. 14 (1) , 2538684
Open AccessSystematic identification of lincRNA-derived immunogenic peptides in melanoma
The search for reliable shared tumor-specific antigens (TSAs) to improve cancer immunotherapy is on-going. The so-called non-coding regions of the genome have recently been shown to give rise to immunogenic peptides, including the melanoma-specific antigen MELOE-1 which is translated from the long intergenic non-coding RNA (lincRNA) meloe in an IRES-dependent manner. Here, we present a strategy to systematically identify tumor-specific antigens produced by ORFs within lincRNAs with IRES-like upstream structures. We provide evidence suggesting that in the melanocytic lineage a significant proportion of the selected lincRNAs can produce immunogenic peptides. T cell repertoires against some of these peptides were found in peripheral blood mononuclear cells (PBMCs) from healthy donors and melanoma patients, and in tumor-infiltrating lymphocytes (TILs) from metastatic melanoma patients. Finally, CD8+ T cell lines from melanoma patients specific for three of the characterized HLA-A *0201 epitopes could recognize melanoma cell lines, which were enhanced by reticular stress. Thus, these peptides may represent a new class of shared TSAs in melanoma and are attractive candidates for evaluation as targets for immunotherapy in preclinical studies. In addition, our selection strategy has the potential to identify new lincRNA-derived antigens in other cancers.
- Open Access
Antibacterial activity of human natural killer cells in the absence of accessory cells against extracellular Staphylococcus aureus and hypervirulent Pseudomonas aeruginosa bacteria
Natural killer (NK) cells play a crucial role in the innate immune response to bacterial infections, including those due to Pseudomonas aeruginosa ( P. aeruginosa ) and Staphylococcus aureus ( S. aureus ). In vivo , it has been shown that NK cells are activated by innate accessory cells that detect the presence of bacteria and activate NK cells via a cytokine network. In vitro , several studies have shown that NK cells can also be activated without the help of accessory cells by direct contact with some bacteria species such as extracellular P. aeruginosa . Whether this phenomenon of direct activation is restricted to certain bacterial species, or whether it can be generalized, is still debated, as for example in the case of NK cell activation by S. aureus , which seems to require the intervention of accessory immune cells. Here, we show with co-incubation experiments between NK cells and two bacterial species, that, in the absence of accessory cells, NK cells are able to impede bacterial growth. This has been demonstrated for the P. aeruginosa PA14 strain, which is hypervirulent and known for its deleterious effects on NK cells, as well as for the S. aureus Newman strain. The monitoring of CD107a by flow cytometry suggests that NK cells degranulate after contact with S. aureus bacteria. Our study contributes to the idea that NK cells can be activated in the absence of any accessory cells by various species of bacteria, even an hypervirulent one, and therefore that NKs can directly have an antibacterial effect. This important insight may pave the way for new therapeutic approaches using antibacterial NK-cell engagers.
Open AccessAntibacterial activity of human natural killer cells in the absence of accessory cells against extracellular Staphylococcus aureus and hypervirulent Pseudomonas aeruginosa bacteria
Natural killer (NK) cells play a crucial role in the innate immune response to bacterial infections, including those due to Pseudomonas aeruginosa ( P. aeruginosa ) and Staphylococcus aureus ( S. aureus ). In vivo , it has been shown that NK cells are activated by innate accessory cells that detect the presence of bacteria and activate NK cells via a cytokine network. In vitro , several studies have shown that NK cells can also be activated without the help of accessory cells by direct contact with some bacteria species such as extracellular P. aeruginosa . Whether this phenomenon of direct activation is restricted to certain bacterial species, or whether it can be generalized, is still debated, as for example in the case of NK cell activation by S. aureus , which seems to require the intervention of accessory immune cells. Here, we show with co-incubation experiments between NK cells and two bacterial species, that, in the absence of accessory cells, NK cells are able to impede bacterial growth. This has been demonstrated for the P. aeruginosa PA14 strain, which is hypervirulent and known for its deleterious effects on NK cells, as well as for the S. aureus Newman strain. The monitoring of CD107a by flow cytometry suggests that NK cells degranulate after contact with S. aureus bacteria. Our study contributes to the idea that NK cells can be activated in the absence of any accessory cells by various species of bacteria, even an hypervirulent one, and therefore that NKs can directly have an antibacterial effect. This important insight may pave the way for new therapeutic approaches using antibacterial NK-cell engagers.